Citations

Showing 10 of 108152 citations.

Transthyretin amyloidosis: Putting myopathy on the map
Pinto, Marcus Vinícius , Milone, Margherita , Mauermann, Michelle L. , Dyck, P. James B. , Alhammad, Reem , Grogan, Martha , Liewluck, Teerin , Pinto, Marcus V , Liewluck, T , Mauermann, Michelle L , McPhail, Ellen Darcy

Mayo Clinic

Muscle & Nerve | October 6, 2019 | Volume: 61 | Issue: 1 | Pages: 95-100

10.1002/mus.26723 | PMID 31587306 Get It

Abstract Introduction Although peripheral neuropathy and cardiomyopathy are well‐recognized manifestations of transthyretin (ATTR) amyloidosis, myopathy has been rarely reported. Methods In this study we reviewed our muscle biopsy database (January 1998 to June 2018) to identify patients with ATTR amyloid myopathy confirmed by molecular or proteomic analysis. Clinical and laboratory findings were reviewed. Results We identified eight ATTR amyloid myopathy patients (5 hereditary ATTR [ATTRv] and 3 wild‐type ATTR [ATTRwt]). Myopathy was the initial manifestation in all ATTRwt patients and followed peripheral neuropathy (4 patients) or cardiomyopathy (1 patient) in ATTRv patients. One ATTRv patient developed myopathy after liver transplant. Peripheral neuropathy and cardiac amyloidosis occurred in seven and six patients, respectively. Muscle biopsy showed interstitial amyloid deposition in all patients, rare necrotic/regenerating fibers in six, and vacuoles in four. Discussion Myopathy can be the initial manifestation of ATTRwt amyloidosis and can precede the peripheral neuropathy or occur after liver transplant in ATTRv amyloidosis.
Robot Assisted Surgery of the Vena Cava: Perioperative Outcomes, Technique, and Lessons Learned at The Mayo Clinic
Navaratnam, Anojan , Abdul-Muhsin, Haidar , Eversman, Sarah, Moss, Adyr A. , Eversman, William G. , Stone, William M., Money, Samuel R., Davila, Victor J. , Castle, Erik P., Rose, Kyle M., Navaratnam, Anojan K, Abdul-Muhsin, Haidar M., Faraj, Kassem S, Eversman, Sarah A, Rose, Kyle , Faraj, Kassem

Mayo Clinic

Journal of Endourology | October 5, 2019 | Volume: 33 | Issue: 12 | Pages: 1009-1016

10.1089/end.2019.0429 | PMID 31588787 Get It

Introduction: This study aims to describe robot assisted surgery of the inferior vena cava (IVC) by assessing techniques utilized, perioperative outcomes, complications, and long-term patency of the IVC. Methods: A retrospective review was performed on all robotic surgeries involving dissection and repair of the IVC at our institution. Patient characteristics, operative reports, and follow-up visits were analyzed. Preoperative and postoperative imaging was independently reviewed by a single radiologist to determine changes in IVC diameter. Complications were analyzed according to early (<30 days) vs late (>30 days). Results: Thirty-four patients underwent robot assisted surgery of the vena cava from 2008 to 2018. Twenty-six cases were performed for urologic malignancy, four were performed for IVC filter explantation, and four renal vein transpositions were performed for nutcracker syndrome. Twenty-four of the 26 patients with urologic malignancy underwent radical nephrectomy with IVC tumor thrombectomy. Three cases were converted to open. Median length of stay was two nights, and mean estimated blood loss (EBL) was 375 mL. There were five complications, ranging from Clavien-Dindo grade II–IIIa, four of which were early complications. No patients required return to the operating room, and there were no perioperative mortalities. IVC diameter was reduced by 41% on axial diameter, with no patients experiencing compromised venous return. Conclusion: Robot assisted surgery offers the advantage of minimally invasive surgery with the ability to apply open surgical principles. In our series, an experienced multidisciplinary team approach yielded low EBL, short length of stay, and low complication rates.
Cervicocerebral quantitative arterial tortuosity: a biomarker of arteriopathy in children with intracranial aneurysms
Chen, Alan M., Karani, Kunal B. , Taylor, J. Michael , Zhang, Bin , Furthmiller, Andrew , Vela, Gabriel De, Leach, James L. , Vadivelu, Sudhakar , Abruzzo, Todd , Abruzzo, Todd A

Mayo Clinic

Journal of Neurosurgery: Pediatrics | October 4, 2019 | Volume: 24 | Issue: 4 | Pages: 389-396

10.3171/2019.5.peds1982 | PMID 31349231 Get It

OBJECTIVEAlthough intracranial arterial aneurysms (IAAs) of childhood are usually idiopathic, it is possible that underlying arteriopathy escapes detection when using conventional diagnostic tools. Quantitative arterial tortuosity (QAT) has been studied as a biomarker of arteriopathy. The authors analyzed cervicocerebral QAT in children with idiopathic IAAs to assess the possibility of arteriopathy.METHODSCases were identified by text-string searches of imaging reports spanning the period January 1993 through June 2017. QAT of cervicocerebral arterial segments was measured from cross-sectional studies using image-processing software. Other imaging and clinical data were confirmed by retrospective electronic record review. Children with idiopathic IAAs and positive case controls, with congenital arteriopathy differentiated according to aneurysm status (with and without an aneurysm), were compared to each other and to healthy controls without vascular risk factors.RESULTSCervicocerebral QAT was measured in 314 children: 24 with idiopathic IAAs, 163 with congenital arteriopathy (including 14 arteriopathic IAAs), and 127 healthy controls. QAT of all vertebrobasilar segments was larger in children with IAAs (idiopathic and arteriopathic forms) (p < 0.05). In children with congenital arteriopathy without an aneurysm, QAT was decreased for the distal cervical vertebral arteries and increased for the supraspinal vertebral artery relative to healthy children. QAT of specific cervicocerebral segments correlated with IAA size and rupture status.CONCLUSIONSCervicocerebral QAT is a biomarker of arteriopathy in children with IAA, even in the absence of other disease markers. Additional findings suggest a correlation of cervicocerebral QAT with IAA size and rupture status and with the presence of IAA in children with congenital arteriopathy.
Progressive hydrocephalus despite early complete reversal of hindbrain herniation after prenatal open myelomeningocele repair
Lu, Victor M. , Snyder, Kendall, Ibirogba, Eniola R. , Ahn, Edward S. , Ibirogba, Eniola R , Ruano, Rodrigo , Daniels, David J.

Mayo Clinic

Neurosurgical Focus | October 4, 2019 | Volume: 47 | Issue: 4 | Pages: E13

10.3171/2019.7.focus19434 | PMID 31574467 Get It

OBJECTIVE Open prenatal myelomeningocele (MMC) repair is typically associated with reversal of in utero hindbrain herniation (HBH) and has been posited to be associated with a reduction in both postoperative prenatal and immediate postnatal hydrocephalus (HCP) risks. However, the long-term postnatal risk of HCP following HBH reversal in these cases has not been well defined. The authors describe the results of a long-term HCP surveillance in a cohort of patients who underwent prenatal MMC repair at their institution. METHODS A retrospective review of all prenatal MMC repair operations performed at the Mayo Clinic between 2012 and 2017 was conducted. Pertinent data regarding the clinical courses of these patients before and after MMC repair were summarized. Outcomes of interest were occurrences of HBH and HCP and the need for intervention. RESULTS A total of 9 prenatal MMC repair cases were identified. There were 7 cases in which MRI clearly demonstrated prenatal HBH, and of these 86% (6/7) had evidence of HBH reversal after repair and prior to delivery. After a mean postnatal follow-up of 20 months, there were 3 cases of postnatal HCP requiring intervention. One case that failed to show complete HBH reversal after MMC repair required early ventriculoperitoneal shunting. The other 2 cases were of progressive, gradual-onset HCP despite complete prenatal HBH reversal, requiring endoscopic third ventriculostomy with choroid plexus cauterization at ages 5 and 7 months. CONCLUSIONS Although prenatal MMC repair can achieve HBH reversal in a majority of well-selected cases, the prevention of postnatal HCP requiring intervention appears not to be predicated on this outcome alone. In fact, it appears that in a subset of cases in which HBH reversal is achieved, patients can experience a progressive, gradual-onset HCP within the 1st year of life. These findings support continued rigorous postnatal surveillance of all prenatal MMC repair patients, irrespective of postoperative HBH outcome.
Pediatric neurosurgeons’ views regarding prenatal surgery for myelomeningocele and the management of hydrocephalus: a national survey
Riley, John S. , Antiel, Ryan M. , Flake, Alan W. , Rintoul, Natalie E. , Lantos, John D. , Traynor, Michael D. , Adzick, N. Scott , Heuer, Gregory G. , Johnson, Mark Paul , Feudtner, Chris

Mayo Clinic

Neurosurgical Focus | October 4, 2019 | Volume: 47 | Issue: 4 | Pages: E8

10.3171/2019.7.focus19406 | PMID 31574481 Get It

OBJECTIVE The Management of Myelomeningocele Study (MOMS) compared prenatal with postnatal surgery for myelomeningocele (MMC). The present study sought to determine how MOMS influenced the clinical recommendations of pediatric neurosurgeons, how surgeons’ risk tolerance affected their views, how their views compare to those of their colleagues in other specialties, and how their management of hydrocephalus compares to the guidelines used in the MOMS trial. METHODS A cross-sectional survey was sent to all 154 pediatric neurosurgeons in the American Society of Pediatric Neurosurgeons. The effect of surgeons’ risk tolerance on opinions and counseling of prenatal closure was determined by using ordered logistic regression. RESULTS Compared to postnatal closure, 71% of responding pediatric neurosurgeons viewed prenatal closure as either “very favorable” or “somewhat favorable,” and 51% reported being more likely to recommend prenatal surgery in light of MOMS. Compared to pediatric surgeons, neonatologists, and maternal-fetal medicine specialists, pediatric neurosurgeons viewed prenatal MMC repair less favorably (p < 0.001). Responders who believed the surgical risks were high were less likely to view prenatal surgery favorably and were also less likely to recommend prenatal surgery (p < 0.001). The management of hydrocephalus was variable, with 60% of responders using endoscopic third ventriculostomy in addition to ventriculoperitoneal shunts. CONCLUSIONS The majority of pediatric neurosurgeons have a favorable view of prenatal surgery for MMC following MOMS, although less so than in other specialties. The reported acceptability of surgical risks was strongly predictive of prenatal counseling. Variation in the management of hydrocephalus may impact outcomes following prenatal closure.
Dual-Energy Computed Tomography in Thoracic Imaging—Current Practices and Utility
Rajiah, Prabhakar , Rajiah, Prabhakar

Mayo Clinic

Journal of Thoracic Imaging | October 4, 2019 | Volume: 35 | Issue: 2 | Pages: W43-W50

10.1097/rti.0000000000000450 | PMID 31584479 Get It

Purpose: The purpose of this study was to determine the current practice patterns of utilization of dual-energy computed tomography (DECT) in thoracic imaging. Materials and Methods: In this IRB-approved study, the URL link for an anonymous 26-question survey was sent by email to all the members of the Society of Thoracic Radiology (STR). Survey questions focused on the practice type, case volume, DECT scanner availability, common indications, image types, and perceived utility of DECT. Study data were collected and managed using SurveyMonkey tools and analyzed with χ2 tests. Results: The survey response rate was 11% (104/962). DECT was available in 75% of respondents’ institutions, with 90% of these having 1 to 5 DECT scanners (P<0.001). Seventy percent performed 1 to 500 DECT chest CTs per month (P<0.001). Dual-source was the most common DECT scanner (81%) (P=0.239). DECT was opted depending on the clinical indication in 89% (P=0.433). The technologist reconstructs the additional DECT images in 75% of instances (P<0.001). Acute pulmonary embolism (PE) was the most common indication of DECT (53%) (P=0.006), while chronic PE was considered the most valuable use of DECT (33%) (P<0.001). Iodine map was the most commonly used DECT image (53%) (P<0.001) followed by low-energy virtual monoenergetic image (VMI) (29%). For VMI, 50 keV was the most commonly used energy level for improving vascular contrast (43%) (P=0.048), whereas 120 keV was the most commonly used energy in VMI for decreasing artifacts (25%) (P=0.027). Conclusions: There is wide variability on the utilization of DECT in thoracic imaging. PE is perceived to be the most valuable utility of DECT, and iodine map is considered the most valuable DECT image.
Sudden blastic transformation in treatment‐free remission chronic myeloid leukaemia
Richard‐Carpentier, Guillaume , Vishnu, Prakash , Naqvi, Kiran , Sasaki, Koji , Cortes, Jörge E. , Pemmaraju, Naveen , Alfayez, Mansour , Sasaki, Koji , Cortes, Jorge , Vishnu, Prakash , Jabbour, Elias

Mayo Clinic

British Journal of Haematology | October 4, 2019 | Volume: 187 | Issue: 4 | Pages: 543-545

10.1111/bjh.16245 | PMID 31584727 Get It

PADS Arsenal: a database of prokaryotic defense systems related genes
Zhang, Yadong , Zhang, Zhewen , Zhao, Yongbing , Zhang, Zaichao , Xiao, Jingfa , Zhang, Hao

Mayo Clinic

Nucleic Acids Research | October 4, 2019 | Volume: 48 | Issue: D1 | Pages: D590-D598

10.1093/nar/gkz916 | PMID 31620779 Get It

AbstractDefense systems are vital weapons for prokaryotes to resist heterologous DNA and survive from the constant invasion of viruses, and they are widely used in biochemistry investigation and antimicrobial drug research. So far, numerous types of defense systems have been discovered, but there is no comprehensive defense systems database to organize prokaryotic defense gene datasets. To fill this gap, we unveil the prokaryotic antiviral defense system (PADS) Arsenal (https://bigd.big.ac.cn/padsarsenal), a public database dedicated to gathering, storing, analyzing and visualizing prokaryotic defense gene datasets. The initial version of PADS Arsenal integrates 18 distinctive categories of defense system with the annotation of 6 600 264 genes retrieved from 63,701 genomes across 33 390 species of archaea and bacteria. PADS Arsenal provides various ways to retrieve defense systems related genes information and visualize them with multifarious function modes. Moreover, an online analysis pipeline is integrated into PADS Arsenal to facilitate annotation and evolutionary analysis of defense genes. PADS Arsenal can also visualize the dynamic variation information of defense genes from pan-genome analysis. Overall, PADS Arsenal is a state-of-the-art open comprehensive resource to accelerate the research of prokaryotic defense systems.
Evaluating a combined bowel preparation for small-bowel capsule endoscopy: a prospective randomized–controlled study
Alexander, Jeffrey A. , Bruining, David H. , Larson, Mark V., Mangan, Thomas F., Dierkhising, Ross , Almazar, Ann E., Rajan, Elizabeth , Hansel, Stephanie L. , Dierkhising, Ross A, Murray, Joseph A.

Mayo Clinic

Gastroenterology Report | October 4, 2019 | Volume: 8 | Issue: 1 | Pages: 31-35

10.1093/gastro/goz054 | PMID 32419949 Get It

Abstract Background Capsule endoscopy (CE) is frequently hindered by intra-luminal debris. Our aim was to determine whether a combination bowel preparation would improve small-bowel visualization, diagnostic yield, and the completion rate of CE. Methods Single-blind, prospective randomized–controlled study of outpatients scheduled for CE. Bowel-preparation subjects ingested 2 L of polyethylene glycol solution the night prior to CE, 5 mL simethicone and 5 mg metoclopramide 20 minutes prior to CE and laid in the right lateral position 30 minutes after swallowing CE. Controls had no solid food after 7 p.m. the night prior to CE and no liquids 4 hours prior to CE. Participants completed a satisfaction survey. Capsule readers completed a small-bowel-visualization assessment. Results Fifty patients were prospectively enrolled (56% female) with a median age of 54.4 years and 44 completed the study (23 patients in the control group and 21 in the preparation group). There was no significant difference between groups on quartile-based small-bowel visualization (all P &gt; 0.05). There was no significant difference between groups in diagnostic yield (P = 0.69), mean gastric (P = 0.10) or small-bowel transit time (P = 0.89). The small-bowel completion rate was significantly higher in the preparation group (100% vs 78%; P = 0.02). Bowel-preparation subjects reported significantly more discomfort than controls (62% vs 17%; P = 0.01). Conclusions Combined bowel preparation did not improve small-bowel visualization but did significantly increase patient discomfort. The CE completion rate improved in the preparation group but the diagnostic yield was unaffected. Based on our findings, a bowel preparation prior to CE does not appear to improve CE performance and results in decreased patient satisfaction (ClinicalTrials.gov, No. NCT01243736).